Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other current liabilities

v3.8.0.1
Accrued expenses and other current liabilities
3 Months Ended
Mar. 31, 2018
Accrued expenses and other current liabilities  
Accrued expenses and other current liabilities

 

Note 9 — Accrued expenses and other current liabilities

 

Accrued expenses and other current liabilities consisted of the following (in thousands):

 

 

March 31,
2018

 

December 31,
2017

 

Accrued clinical and development expenditure

 

$

10,212

 

$

10,065

 

Accrued employee expenses

 

4,084

 

6,592

 

VAT

 

458

 

5,741

 

Other accrued expenditure

 

3,829

 

3,944

 

Accrued capital expenditure

 

585

 

502

 

Other liabilities

 

482

 

357

 

 

 

 

 

 

 

 

 

$

19,650

 

$

27,201